Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 1

Status

Completed 4Terminated 1

Sponsor Class

OTHER 18NIH 5INDUSTRY 4

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 11Head & Neck 5Gastrointestinal 5CNS 4Sarcoma 3Other solid neoplasm 3Gynecologic 3Genitourinary 2Endocrine 2Dermatologic 2Breast 2

Conditions

Rectal Neoplasms 4Colonic Neoplasms 4Colorectal Neoplasms 3Carcinoma, Hepatocellular 1

Interventions

Fluorouracil 126Leucovorin 90Oxaliplatin 82Specimen Handling 71Gemcitabine 61Magnetic Resonance Spectroscopy 55Irinotecan 55Biopsy 53Capecitabine 40Bevacizumab 40Radiotherapy 37Cisplatin 34Cetuximab 29Chemotherapy, Adjuvant 28Erlotinib Hydrochloride 26Neoadjuvant Therapy 21dehydroftorafur 20Cyclophosphamide 19Nivolumab 18Sorafenib 17Radiation 17Paclitaxel 17X-Rays 16Doxorubicin 16aldesleukin 14Immunoglobulin G 14Disulfides 14fludarabine 13Folfox protocol 13Carboplatin 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
NIH × Gefitinib × Gastrointestinal × Clear all
NCT00025350 2013-06-24

Gefitinib in Treating Patients With Recurrent Metastatic Colorectal Cancer

National Cancer Institute (NCI)

Phase 2 Completed
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00025142 2013-05-15

Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal Cancer

National Cancer Institute (NCI)

Phase 2 Completed
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00026364 2013-03-21

ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Colorectal Cancer

National Cancer Institute (NCI)

Phase 1 Completed
22 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00071994 2013-02-27

Gefitinib in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)

National Cancer Institute (NCI)

Phase 2 Completed
59 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT00052585 2013-01-16

Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancer

National Cancer Institute (NCI)

Phase 2 Terminated
50 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡